首页> 外文期刊>World Allergy Organization Journal >Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement
【24h】

Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement

机译:过敏学诊断和治疗程序的风险和安全要求:世界过敏组织声明

获取原文
           

摘要

One of the major concerns in the practice of allergy is related to the safety of procedures for the diagnosis and treatment of allergic disease. Management (diagnosis and treatment) of hypersensitivity disorders involves often intentional exposure to potentially allergenic substances (during skin testing), deliberate induction in the office of allergic symptoms to offending compounds (provocation tests) or intentional application of potentially dangerous substances (allergy vaccine) to sensitized patients. These situations may be associated with a significant risk of unwanted, excessive or even dangerous reactions, which in many instances cannot be completely avoided. However, adverse reactions can be minimized or even avoided if a physician is fully aware of potential risk and is prepared to appropriately handle the situation. Information on the risk of diagnostic and therapeutic procedures in allergic diseases has been accumulated in the medical literature for decades; however, except for allergen specific immunotherapy, it has never been presented in a systematic fashion. Up to now no single document addressed the risk of the most commonly used medical procedures in the allergy office nor attempted to present general requirements necessary to assure the safety of these procedures. Following review of available literature a group of allergy experts within the World Allergy Organization (WAO), representing various continents and areas of allergy expertise, presents this report on risk associated with diagnostic and therapeutic procedures in allergology and proposes a consensus on safety requirements for performing procedures in allergy offices. Optimal safety measures including appropriate location, type and required time of supervision, availability of safety equipment, access to specialized emergency services, etc. for various procedures have been recommended. This document should be useful for allergists with already established practices and experience as well as to other specialists taking care of patients with allergies.
机译:过敏实践中的主要关注之一与诊断和治疗过敏性疾病的程序的安全性有关。超敏性疾病的管理(诊断和治疗)通常涉及到有意暴露于潜在的致敏物质(在皮肤测试期间),故意在办公室诱发诱发过敏性物质的过敏症状(激发试验)或有意将潜在危险物质(过敏疫苗)应用于致敏患者。这些情况可能会带来很大的不希望的,过度的,甚至是危险的反应风险,在许多情况下这是无法完全避免的。但是,如果医生充分意识到潜在的风险并准备适当地处理这种情况,则可以最大程度地减少甚至避免不良反应。关于过敏性疾病的诊断和治疗程序风险的信息已在医学文献中积累了数十年;但是,除了过敏原特异性免疫疗法外,从未以系统的方式进行介绍。迄今为止,还没有任何文件解决过敏办公室最常用的医疗程序的风险,也没有试图提出确保这些程序安全的必要一般要求。查阅现有文献后,代表各个大洲和不同领域的过敏症专家组成的世界过敏组织(WAO)中的过敏专家小组提出了有关过敏学诊断和治疗程序相关风险的报告,并就执行安全要求提出了共识过敏办公室的程序。对于各种程序,建议采取最佳的安全措施,包括适当的位置,类型和所需的监督时间,安全设备的可用性,获得专业紧急服务的权限等。该文档对于已经建立了实践和经验的过敏症患者以及对患有过敏症患者进行护理的其他专家应该是有用的。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号